Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
brain cancer
Biotech
BrainChild aims for paradigm shift on pediatric CAR T therapies
Rather than starting with regulatory approval for its drugs in adults, BrainChild Bio will aim for a greenlight for peds patients first.
Helen Floersh
Dec 5, 2023 9:06am
'Quantum therapeutic' sparks glioblastoma cells to self-destruct
Sep 18, 2023 11:00am
Chinese and Korean biotechs expand ADC collaboration
Jul 7, 2023 8:55am
ASCO: Servier finds survival benefit in difficult brain cancer
Jun 5, 2023 8:55am
DeepGlioma AI classifies brain tumors within 90 seconds: study
Mar 27, 2023 8:15am
Servier’s $1.8B bet on Agios delivers phase 3 brain tumor win
Mar 14, 2023 10:15am